Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-25-010250
Filing Date
2025-03-31
Accepted
2025-03-31 17:01:28
Documents
89
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K acrx20241231_10k.htm   iXBRL 10-K 1956489
2 EXHIBIT 10.11 ex_786515.htm EX-10.11 21066
3 EXHIBIT 19 ex_786516.htm EX-19 91853
4 EXHIBIT 23.1 ex_786511.htm EX-23.1 2584
5 EXHIBIT 31.1 ex_786512.htm EX-31.1 8286
6 EXHIBIT 31.2 ex_786513.htm EX-31.2 8274
7 EXHIBIT 32.1 ex_786514.htm EX-32.1 5414
  Complete submission text file 0001437749-25-010250.txt   9704145

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA tlph-20241231.xsd EX-101.SCH 89256
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tlph-20241231_def.xml EX-101.DEF 605212
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE tlph-20241231_lab.xml EX-101.LAB 502633
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tlph-20241231_pre.xml EX-101.PRE 640128
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tlph-20241231_cal.xml EX-101.CAL 50654
92 EXTRACTED XBRL INSTANCE DOCUMENT acrx20241231_10k_htm.xml XML 1508967
Mailing Address 1850 GATEWAY DRIVE SUITE 175 SAN MATEO CA 94404
Business Address 1850 GATEWAY DRIVE SUITE 175 SAN MATEO CA 94404 650-216-3500
TALPHERA, INC. (Filer) CIK: 0001427925 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35068 | Film No.: 25794667
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)